These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 22438051)
1. Using neoadjuvant therapy for breast cancer in clinical practice: when and how? Tripathy D Breast Cancer Res Treat; 2012 Apr; 132(3):775-7. PubMed ID: 22438051 [No Abstract] [Full Text] [Related]
2. [Sentinel lymph node and neoadjuvant therapy in breast cancer: searching for the best scenario]. Solá M; Fraile M Rev Esp Med Nucl; 2010; 29(6):316-8. PubMed ID: 21055516 [No Abstract] [Full Text] [Related]
3. [Sentinel lymph node and neoadjuvant therapy in breast cancer]. Muñoz M; Pahisa J; Xavier Caparrós F; Vidal-Sicart S Rev Esp Med Nucl; 2010; 29(6):319-20. PubMed ID: 21055517 [No Abstract] [Full Text] [Related]
4. Pathologic complete response after neoadjuvant therapy of breast cancer: pitfalls and shortcomings. von Minckwitz G Breast Cancer Res Treat; 2012 Apr; 132(3):779-80. PubMed ID: 22460616 [No Abstract] [Full Text] [Related]
5. Neoadjuvant endocrine therapy for breast cancer: medical perspectives. Ellis MJ Clin Cancer Res; 2001 Dec; 7(12 Suppl):4388s-4391s; discussion 4411s-4412s. PubMed ID: 11916229 [TBL] [Abstract][Full Text] [Related]
6. Preoperative therapy for breast cancer. Sledge GW Clin Breast Cancer; 2007 Apr; 7(7):525. PubMed ID: 17509160 [No Abstract] [Full Text] [Related]
7. Neoadjuvant therapy for breast cancer. Liu SV; Melstrom L; Yao K; Russell CA; Sener SF J Surg Oncol; 2010 Mar; 101(4):283-91. PubMed ID: 20187061 [TBL] [Abstract][Full Text] [Related]
8. [Neoadjuvant therapy in breast cancer]. Ena G Rev Med Brux; 2011 Sep; 32(4):243-6. PubMed ID: 22034752 [TBL] [Abstract][Full Text] [Related]
9. Standardization of pathologic complete response rates in breast cancer treatment. Knauer M; Devries A; Wenzl E; Haid A Breast Cancer Res Treat; 2008 Jul; 110(2):395-6. PubMed ID: 17851755 [No Abstract] [Full Text] [Related]
10. Breast cancer: role of neoadjuvant therapy. Ahmed MI; Lennard TW Int J Surg; 2009 Oct; 7(5):416-20. PubMed ID: 19524705 [TBL] [Abstract][Full Text] [Related]
11. The role of neoadjuvant chemotherapy in the management of primary breast cancer. Aigner J; Schneeweiss A; Sohn C; Marmé F Minerva Ginecol; 2011 Jun; 63(3):261-74. PubMed ID: 21654611 [TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant/primary chemotherapy in cancer treatment: what advantage? Wynendaele W; van Oosterom AT Forum (Genova); 1999; 9(3):212-21. PubMed ID: 10504169 [TBL] [Abstract][Full Text] [Related]
13. Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer. Kaufmann M; von Minckwitz G; Mamounas EP; Cameron D; Carey LA; Cristofanilli M; Denkert C; Eiermann W; Gnant M; Harris JR; Karn T; Liedtke C; Mauri D; Rouzier R; Ruckhaeberle E; Semiglazov V; Symmans WF; Tutt A; Pusztai L Ann Surg Oncol; 2012 May; 19(5):1508-16. PubMed ID: 22193884 [TBL] [Abstract][Full Text] [Related]
14. Review of the development of letrozole and its use in advanced breast cancer and in the neoadjuvant setting. Bhatnagar AS Breast; 2006 Feb; 15 Suppl 1():S3-13. PubMed ID: 16500235 [TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant endocrine therapy for breast cancer: more questions than answers. Ellis MJ J Clin Oncol; 2005 Aug; 23(22):4842-4. PubMed ID: 15998901 [No Abstract] [Full Text] [Related]
16. Neoadjuvant chemotherapy for breast carcinoma: multidisciplinary considerations of benefits and risks. Buchholz TA; Hunt KK; Whitman GJ; Sahin AA; Hortobagyi GN Cancer; 2003 Sep; 98(6):1150-60. PubMed ID: 12973838 [TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant systemic treatment of breast cancer. Makhoul I; Kiwan E J Surg Oncol; 2011 Mar; 103(4):348-57. PubMed ID: 21337570 [TBL] [Abstract][Full Text] [Related]
18. Preoperative therapy as a model for translational research in breast cancer. Burstein HJ Cancer Invest; 2008; 26(3):217-21. PubMed ID: 18317961 [No Abstract] [Full Text] [Related]
19. Neoadjuvant chemotherapy for early breast cancer. Mieog JS; van de Velde CJ Expert Opin Pharmacother; 2009 Jun; 10(9):1423-34. PubMed ID: 19505212 [TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant endocrine therapy for postmenopausal patients with hormone receptor-positive early breast cancer: a new concept. Iwata H Breast Cancer; 2011 Apr; 18(2):92-7. PubMed ID: 21140250 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]